These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3309548)

  • 1. Effects of intraduodenal nutrient infusion on insulin response to subsequent intravenous glucose in rats.
    Ikeda T; Yoshida T; Honda M; Ito Y; Mokuda O; Tominaga M; Mashiba H
    Metabolism; 1987 Oct; 36(10):979-82. PubMed ID: 3309548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
    Boden G; Essa N; Owen OE; Reichle FA
    J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
    Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
    Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
    Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic stimulation contributes to incretin effect in conscious dogs.
    Chap Z; Okuda Y; Peña J; Field JB
    Am J Physiol; 1991 Jul; 261(1 Pt 1):E58-65. PubMed ID: 1650140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.
    Balkan B; Li X
    Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1449-54. PubMed ID: 11004015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.
    Burcelin R; Da Costa A; Drucker D; Thorens B
    Diabetes; 2001 Aug; 50(8):1720-8. PubMed ID: 11473030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intestinal osmolality on insulin secretion to subsequent intravenous glucose or arginine in the rat.
    Ikeda T; Fujiyama K; Hoshino T; Takeuchi T; Mashiba H; Tominaga M
    Proc Soc Exp Biol Med; 1990 Sep; 194(4):342-5. PubMed ID: 2117758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the route of glucose administration on hepatic glycogen repletion.
    Shulman GI; Rossetti L
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E681-5. PubMed ID: 2688436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
    Ohneda A; Parada E; Eisentraut AM; Unger RH
    J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
    Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Horowitz M; Jones KL; Rayner CK
    Diab Vasc Dis Res; 2017 Jan; 14(1):59-63. PubMed ID: 27941058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA
    Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.
    Ionut V; Hucking K; Liberty IF; Bergman RN
    Diabetologia; 2005 May; 48(5):967-75. PubMed ID: 15830188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatic portal infusion of hypertonic saline on glucagon response to exercise.
    Latour MG; Bergeron R; Lavoie JM
    Physiol Behav; 1999 Sep; 67(3):377-83. PubMed ID: 10497956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.